PIB binding in aged primate brain: Enrichment of high-affinity sites in humans with Alzheimer's disease

NEUROBIOLOGY OF AGING

卷:32

Article

Rosen, Rebecca F.¹  Walker, Lary C.^1,2  LeVine, Harry, III³ 

[1] Emory Univ, Div Neurosci, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA

[2] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA

[3] Univ Kentucky, Sanders Brown Ctr Aging, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA

关键词: Alzheimer's disease;    A beta;    Benzothiazole;    beta-Amyloid;    Cerebral amyloid angiopathy;    Imaging;    Nonhuman primates;    Pittsburgh Compound B;    Senile plaques;   

DOI  :  10.1016/j.neurobiolaging.2009.02.011

来源: Elsevier

【 摘 要 】

Aged nonhuman primates accumulate large amounts of human-sequence amyloid p (AD) in the brain, yet they do not manifest the full phenotype of Alzheimer's disease (AD). To assess the biophysical properties of Ail that might govern its pathogenic potential in humans and nonhuman primates, we incubated the benzothiazole imaging agent Pittsburgh Compound B (PIB) with cortical tissue homogenates from normal aged humans, humans with AD, and from aged squirrel monkeys, rhesus monkeys, and chimpanzees with cerebral A beta-amyloidosis. Relative to humans with AD, high-affinity PIB binding is markedly reduced in cortical extracts from aged nonhuman primates containing levels of insoluble A beta similar to those in AD. The high-affinity binding of PIB may be selective for a pathologic, human-specific conformation of multimeric A beta, and thus could be a useful experimental tool for clarifying the unique predisposition of humans to Alzheimer's disease. (C) 2009 Elsevier Inc. All rights reserved.

【 授权许可】

Free